Bio-Rad Laboratories (BIO-B) Non-Current Deffered Revenue (2015 - 2016)
Bio-Rad Laboratories (BIO-B) reported Non-Current Deffered Revenue of $4.4 million for Q3 2016, up 17.55% quarter-over-quarter from $3.7 million in Q4 2015.
Bio-Rad Laboratories (BIO-B) Non-Current Deffered Revenue (2015 - 2016) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 2 years of Non-Current Deffered Revenue data on file, last reported at $4.4 million in Q3 2016.
- Non-Current Deffered Revenue for Q3 2016 came in at $4.4 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2016 was $4.4 million (changed N/A YoY), and the FY2015 annual result was $3.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue climbed to $4.4 million in Q3 2016 per BIO-B's latest filing, from $3.7 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $4.4 million in Q3 2016 and troughed at $3.7 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 4.40 Mn |
| Dec 31, 2015 | 3.74 Mn |